Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Bevilacqua

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|October 14, 2022
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic ReviewStefano Salciccia, Marco Frisenda, Giulio Bevilacqua, et al.
Asian Journal of Urology|April 29, 2024
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic reviewStefano Salciccia, Marco Frisenda, Giulio Bevilacqua, et al.
Clinical Genitourinary Cancer|September 27, 2023
Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic Prostate Cancer: Comparative Analysis in Terms of CRPC-M0 ProgressionStefano Salciccia, Marco Frisenda, Antonio Tufano, et al.
Journal of Clinical Medicine|January 11, 2022
How to Predict Outcomes from a Biofeedback and Pelvic Floor Muscle Electric Stimulation Program in Patients with Urinary Incontinence after Radical ProstatectomyStefano Salciccia, Alessandro Sciarra, Martina Moriconi, et al.
Cancers|December 11, 2025
Genitourinary Microbiome and Volatilome: A Pilot Study in Patients with Prostatic Adenocarcinoma Submitted to Radical ProstatectomyLayla Musleh, Sara Passerini, Francesca Brunetti, et al.
European Urology Focus|April 22, 2020
Prospective Evaluation of <sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer DiagnosisEgesta Lopci, Giovanni Lughezzani, Angelo Castello, et al.
Biology|February 26, 2025
Early Detection of the Pathogenetic Variants of Homologous Recombination Repair Genes in Prostate Cancer: Critical Analysis and Experimental DesignIrene Bottillo, Alessandro Sciarra, Giulio Bevilacqua, et al.
Advances in Urology|July 1, 2022
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical ProstatectomyStefano Salciccia, Pietro Viscuso, Giulio Bevilacqua, et al.
The Prostate|October 16, 2025
Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized StudyGiulio Bevilacqua, Dalila Carino, Stefano Salciccia, et al.
World Journal of Urology|November 7, 2019
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) projectRodolfo Hurle, Paolo Casale, Alberto Saita, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|October 14, 2022
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic ReviewStefano Salciccia, Marco Frisenda, Giulio Bevilacqua, et al.
Asian Journal of Urology|April 29, 2024
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic reviewStefano Salciccia, Marco Frisenda, Giulio Bevilacqua, et al.
Clinical Genitourinary Cancer|September 27, 2023
Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic Prostate Cancer: Comparative Analysis in Terms of CRPC-M0 ProgressionStefano Salciccia, Marco Frisenda, Antonio Tufano, et al.
Journal of Clinical Medicine|January 11, 2022
How to Predict Outcomes from a Biofeedback and Pelvic Floor Muscle Electric Stimulation Program in Patients with Urinary Incontinence after Radical ProstatectomyStefano Salciccia, Alessandro Sciarra, Martina Moriconi, et al.
Cancers|December 11, 2025
Genitourinary Microbiome and Volatilome: A Pilot Study in Patients with Prostatic Adenocarcinoma Submitted to Radical ProstatectomyLayla Musleh, Sara Passerini, Francesca Brunetti, et al.
European Urology Focus|April 22, 2020
Prospective Evaluation of <sup>68</sup>Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer DiagnosisEgesta Lopci, Giovanni Lughezzani, Angelo Castello, et al.
Biology|February 26, 2025
Early Detection of the Pathogenetic Variants of Homologous Recombination Repair Genes in Prostate Cancer: Critical Analysis and Experimental DesignIrene Bottillo, Alessandro Sciarra, Giulio Bevilacqua, et al.
Advances in Urology|July 1, 2022
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical ProstatectomyStefano Salciccia, Pietro Viscuso, Giulio Bevilacqua, et al.
The Prostate|October 16, 2025
Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized StudyGiulio Bevilacqua, Dalila Carino, Stefano Salciccia, et al.
World Journal of Urology|November 7, 2019
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) projectRodolfo Hurle, Paolo Casale, Alberto Saita, et al.
Pageof 5